Cluster buy at Aspen Neuroscience, Inc.: four insiders add $68M of ASPE
The largest purchase: $18M by ARCH Venture Partners XIV, L.P., a 10% owner.
Form 4 filings show four Aspen Neuroscience, Inc. insiders buying stock on Nov 2, for a total of $68 million.
The largest purchase came from ARCH Venture Partners XIV, L.P., a 10% owner, who bought 1,200,000 shares for $18 million. Three or more insiders buying within 14 days is what Insider Stock Trader labels a cluster buy.
Peter A. Thompson (director) is the latest to report, in a filing on Nov 4. The table below lists who bought, when, and at what price.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Insider | Role | Trade date | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| ARCH Venture Partners XIV, L.P. | 10% owner | Nov 2 | 1,200,000 | $15.00 | $18,000,000 | App · SEC |
| ARCH Venture Fund X, L.P. | 10% owner | Nov 2 | 133,333 | $15.00 | $1,999,995 | App · SEC |
| ARCH Venture Fund X, L.P. | 10% owner | Nov 2 | 1,200,000 | $15.00 | $18,000,000 | App · SEC |
| Orbimed Advisors LLC | Director | Nov 2 | 1,000,000 | $15.00 | $15,000,000 | App · SEC |
| Peter A. Thompson | Director | Nov 2 | 1,000,000 | $15.00 | $15,000,000 | App · SEC |
| Total | $67,999,995 | |||||
See more details on these ASPE insider trades
Each row of the table links to its Form 4 on SEC.gov.
Read more ASPE insider trading news · Read the daily insider trading roundup
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
